Skip to main content

Table 2 Comparison in different genders between cachexia and non-cachexia cancer patients

From: Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients

 malefemale
Non-cachexia (n = 150)Cachexia (n = 50)pNon-cachexia (n = 87)Cachexia (n = 24)p
Ages (years)62.97 ± 0.8565.32 ± 1.240.15561.24 ± 1.3361.67 ± 2.590.883
BMI (kg/m2)22.82 ± 0.2422.26 ± 0.470.26623.11 ± 0.3321.65 ± 0.670.047
HB (g/L)125.9 ± 1.95115.6 ± 3.920.012108.3 ± 2.68103.8 ± 3.990.416
WBC (10^9/L)5.83 ± 0.156.13 ± 0.310.3355.51 ± 0.185.92 ± 0.400.314
PLT (10^9/L)232.2 ± 5.86259.1 ± 14.070.039241.9 ± 9.46271.1 ± 21.730.174
LY (10^9/L)1.61 ± 0.041.41 ± 0.080.0231.66 ± 0.061.55 ± 0.090.376
TP (g/L)65.18 ± 0.4363.15 ± 0.880.02666.16 ± 0.7765.52 ± 1.720.715
ALB (g/L)40.93 ± 0.3639.3 ± 0.660.02740.78 ± 0.6038.81 ± 1.080.128
PA (g/L)0.219 ± 0.0050.186 ± 0.008<0.0010.199 ± 0.0060.173 ± 0.0110.039
TC (mmol/L)3.97 ± 0.073.84 ± 0.120.3794.53 ± 0.114.05 ± 0.170.043
TG (mmol/L)1.28 ± 0.051.18 ± 0.060.2351.35 ± 0.081.24 ± 0.140.501
ApoA (g/l)155.2 ± 13.81189.5 ± 23.050.206187.3 ± 19.86281.6 ± 60.360.057
ApoB (g/l)0.84 ± 0.020.84 ± 0.040.9050.94 ± 0.030.87 ± 0.050.312
ApoE (g/l)39.37 ± 0.9834.64 ± 1.490.01346.85 ± 1.6539.16 ± 2.280.028
FFA (pg/ml)0.39 ± 0.020.43 ± 0.030.3320.43 ± 0.030.56 ± 0.060.020
IL-6 (pg/ml)5.23 ± 0.376.95 ± 0.840.0374.28 ± 0.407.55 ± 1.250.001
TNF-α (pg/ml)7.547 ± 0.2837.654 ± 0.4240.8499.290 ± 0.8758.09 ± 0.37190.179
(I + II) TNM stage no. (%)76 (50.7%)16 (32.0%)0.02249 (56.3%)8 (33.3%)0.046
  1. BMI Body mass index, HB Hemoglobin, WBC White blood cell count, PLT Platelet, LY Lymphocyte count, TP Total protein, ALB Albumin, PA Prealbumin, TC Total cholesterol, TG Tri-glyceride, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid